CClinicalTrials.gg
CompletedNCT01529281Updated Feb 8, 2012

Exercise-induced Muscle Damage is Reduced in Resistance Trained Athletes by Branch Chain Amino Acids

An interventional study of Branch Chain Amino Acid (BCAA) and Placebo - asparmate in Exercise-induced Muscle Damage, sponsored by Northumbria University. Completed. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-02-08.

Sponsored by Northumbria University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

It is well documented that exercise-induced muscle damage (EIMD) decreases muscle function and causes severe soreness and discomfort. Branched-chain amino acid (BCAA) supplementation has been shown to increase protein synthesis and decrease muscle protein breakdown, however, the effects of BCAAs on recovery from EIMD are unknown. Thus, the aim of this study was to examine the effects of a BCAA supplement on markers of muscle damage.

02

Conditions studied

  • Exercise-induced Muscle Damage
03

In context

Lead sponsor

Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Resistance trained males

Exclusion criteria

Exclusion Criteria:

  • Muscular skeletal disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    BCAA

    Branched chain amino acid

    Dietary Supplement: Branch Chain Amino Acid (BCAA)

  • Placebo comparator
    Asparmate

    Placebo control containing no protein or carbohydrate

    Dietary Supplement: Placebo - asparmate

Interventions

  • Dietary supplementBranch Chain Amino Acid (BCAA)

    Supplementation lasted for a total of 12 days; this was based on previous research showing a positive with BCAA supplementation on markers of muscle damage. Participants ingested 10 g, twice per day (morning and evening) of BCAA . The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The BCAA was in powder form where each serving was mixed with \~300 ml of water.

  • Dietary supplementPlacebo - asparmate

    Supplementation lasted for a total of 12 days. Participants ingested an equivalent looking volume to 10 g of BCAA, twice per day (morning and evening) of placebo (aspartame based artificial sweetener). The BCAA supplement contained a ratio of 2:1:1 (leucine, isoleucine and valine, respectively). The artificial sweetener was in powder form where each serving was mixed with \~300 ml of water.

06

What researchers measure

Primary outcomes

  1. Maximal voluntary contraction

    Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge. MVCs were performed for 3 s with a 60 s rest between each repetition.

    Time frame: pre exercise, 24 h, 48 h, 72 h, 96 h post-exercise

Secondary outcomes

  1. Limb girths

    Mid-thigh and calf circumference was assessed as a measure of limb swelling using an anthropometric tape measure. Both measures were obtained with the participant in a standing position.

    Time frame: pre-exercise, 24h, 48h, 72h, 96h

  2. Vertical jump

    Vertical jump (VJ) performance was assessed using the Vertec instrument. Participants performed a counter movement jump.

    Time frame: pre-exercise, 24h, 48h, 72h, 96h

  3. Creatine kinase

    Plasma CK was determined from an earlobe capillary blood sample. The sample (30 microlitres) was analysed immediately using an automated, dry slide photospectrometer.

    Time frame: pre-exercise, 24h, 48h, 72h, 96h

  4. Muscle soreness

    Muscle soreness - Participants were asked to perform and hold a squat (90° knee angle) whilst they rated their perceived muscle soreness on a 200 mm visual analogue scale. The scale consisted of a line from 0 mm (no pain) to 200 mm (unbearably painful).

    Time frame: pre-exercise, 24h, 48h, 72h, 96h

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Howatson G, Hoad M, Goodall S, Tallent J, Bell PG, French DN. Exercise-induced muscle damage is reduced in resistance-trained males by branched chain amino acids: a randomized, double-blind, placebo controlled study. J Int Soc Sports Nutr. 2012 Jul 12;9:20. doi: 10.1186/1550-2783-9-20. eCollection 2012. PubMed 22569039 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01529281
Lead sponsor
Northumbria University
Responsible party
Sponsor
First posted
Feb 8, 2012
Start date
Jun 2011
Primary completion
Sep 2011
Completion
Sep 2011
Last update
Feb 8, 2012

Study contacts

Glyn Howatson, PhD
principal investigator · Northumbria University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion